Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,427 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07861659Enrolling by invitation
3D-printed vs regular fillings for back tooth cavities
This study compares two ways of filling cavities in the back teeth: a new 3D-printed filling versus a traditional one. It aims to see which lasts longer and works better.
Tanta, EgyptAges 25–40 - NCT07856329RecruitingPhase 2/Phase 3
Gene therapy for duchenne muscular dystrophy
This trial tests a gene therapy to help boys with Duchenne muscular dystrophy (DMD) keep their muscle strength. It aims to see if the treatment is safe and effective for young boys who are still walking.
BrusselsAges 6–10 - NCT06223841RecruitingPhase 1/Phase 2
Testing IAP0971 for advanced solid tumors and lung cancer
This trial tests a new drug, IAP0971, in patients with advanced solid tumors or a specific type of lung cancer (non-small cell lung cancer, or NSCLC) that has high PD-L1 levels. It aims to see if the drug can help when standard treatments have stopped working or are not an option.
Beijing, Beijing MunicipalityAges 18–75 - NCT06270797Recruiting
Pre-anesthesia imaging to assess your breathing passages
This study tests a new way to check your breathing passages using images taken before anesthesia. It aims to help doctors plan safer airways for surgery.
Kaohsiung City, Sanmin DistAges 18–85 - NCT06272552Recruiting
Understanding patient feedback in kidney, cancer, and surgery care
This study aims to understand how patients' feedback and health information can be collected during routine care to improve treatment and communication. It focuses on people being treated for kidney disease, prostate cancer, breast cancer, or bariatric surgery, and will use online tools to gather your input.
Barcelona, CataloniaAges 18 years+ - NCT06272149RecruitingEarly Phase 1
Gene Therapy for Infants With Type 2 Gaucher Disease
This trial tests a new gene therapy (VGN-R08b) for infants with Type 2 Gaucher disease, a rare genetic condition that affects the brain and body. The goal is to see if the treatment is safe and can help improve symptoms.
Shanghai, Shanghai MunicipalityAges birth–2 years - NCT05771688Recruiting
Balloon procedure for severe left lung birth defect
This trial studies a fetal procedure where doctors place a small balloon to help a severe left-sided lung birth defect (CDH) develop better. It aims to improve baby outcomes by temporarily blocking the airway in the womb, starting in a specific week range of pregnancy.
Minneapolis, MinnesotaAges 18 years+ - NCT04810871Recruiting
Surgery for brain tumors that may come back
This study tests whether removing a brain tumor early, before it shows signs of growing back, can help prevent a recurrence. If you have had treatment before and there is still some tumor left, you may be able to join.
Rochester, MinnesotaAges 18 years+ - NCT07868705Enrolling by invitation
Comparing small screws for braces in the upper jaw
This study compares two sizes of tiny screws (called miniscrews) that are sometimes used with braces to help move teeth. The screws are placed in the upper jaw to help correct an overbite where the top teeth stick out too far. The study looks at how well the screws work, how stable they are, and how they feel to patients.
Kuala LumpurAges 13–50 - NCT02753335Recruiting
Rehabilitation for complex regional pain syndrome
This study tests a comprehensive rehabilitation program for adults with complex regional pain syndrome (CRPS), a chronic pain condition usually affecting one arm or leg. It looks at how the program affects pain and brain function, aiming to improve daily life.
TromsøAges 18–70 - NCT07873372Enrolling by invitation
Kidney protection with vitamin C and rutin during vancomycin treatment
This trial tests whether taking vitamin C and rutin (a plant compound) together can help protect the kidneys from damage caused by the antibiotic vancomycin. It compares this combination to vitamin C alone and to no extra supplement.
Cairo, Cairo GovernorateAges 18 years+ - NCT05731830Recruiting
Study how air pollution relates to Takotsubo heart episodes
This study looks at whether levels of air pollution are linked to Takotsubo syndrome (a temporary heart condition). It may help doctors understand what environmental factors could affect episodes and timing.
RomeAges 18 years+ - NCT05714241Recruiting
Blood tests to study heart pain with blocked-unblocked arteries
This study looks at blood “biomarkers” and platelet function to better understand INOCA (heart-related chest pain despite no major artery blockage). You may be eligible if you have INOCA and are already taking aspirin, and if you haven’t taken certain blood-thinner or platelet-altering medicines recently.
RomeAges 18 years+ - NCT05714319Recruiting
Testing acetylcholine during heart artery checks for INOCA/MINOCA
This trial studies what acetylcholine testing during a coronary angiogram (CAG) can show in people with INOCA or MINOCA. It may help doctors better understand certain “spasm” or blood-vessel function problems that can cause chest pain or heart-attack-like symptoms without a blocked artery.
RomeAges 18 years+ - NCT06278870RecruitingPhase 3
New drug combo vs standard for HER2+ advanced breast cancer
This trial compares two drug combinations for HER2-positive breast cancer that has spread. It tests a newer drug (Disitamab Vedotin + Pyrotinib) against a standard treatment (THP) as a first treatment option.
Guangzhou, GuangdongAges 18–75 - NCT05970666RecruitingPhase 2
TACE plus immunotherapy and VEGF drug for unresectable liver cancer
This trial tests whether combining TACE (a liver-targeted chemo procedure) with two medicines—an immune “checkpoint” drug and a blood-vessel blocking drug—can control unresectable hepatocellular carcinoma. It’s designed for people who can’t have surgery or curative ablation, and who still have reasonably strong liver and overall health.
Xiamen, FujianAges 18–75 - NCT07854704Recruiting
Controlled body temperature during long abdominal surgery
This study tests a method to keep the body temperature stable during long abdominal surgery. It may help reduce complications and improve recovery.
Saint PetersburgAges 18 years+ - NCT07862088Recruiting
Managing complications from pancreatitis and pancreatic surgery
This study looks at how doctors treat complications that can happen after severe pancreatitis or pancreatic surgery, such as fluid collections or leaks. It aims to learn which treatments work best for these problems.
Ōtsu, ShigaAges 18 years+ - NCT06103513RecruitingPhase 3
Comparing two starting doses of growth hormone in children
This study compares two different starting doses of growth hormone to see which works better for children who need it. It may help your child grow taller if they have growth hormone deficiency or short stature.
New York, New YorkAges 5–15 - NCT04011020RecruitingPhase 3
Stem cell treatment for type 1 diabetes
This study tests a treatment that uses a patient's own immune cells to help the body make more insulin. It may help people with type 1 diabetes manage their blood sugar better.
Paramus, New JerseyAges 10 years+ - NCT05602610Recruiting
Predicting relapse risk after visceral leishmaniasis
This study looks at a prognostic score to predict whether visceral leishmaniasis (VL) will come back after treatment. If you qualify, your information may help doctors estimate relapse risk and plan follow-up more safely.
GonderAges 12 years+ - NCT06285084Recruiting
Deep learning ECG test for sports eligibility
This trial uses a deep learning computer program to analyze your heart's electrical activity (ECG) during a routine check-up. It aims to help doctors decide if it's safe for you to play competitive sports.
Milan, LombardyAges 18–60 - NCT06101082RecruitingPhase 1
Testing anti-HER2-CAR-T cells for advanced solid tumors
This study tests a new type of cell therapy called anti-HER2-CAR-T for people with advanced HER2-positive solid tumors (like breast, stomach, or colon cancer) whose cancer has not responded to other treatments. The therapy uses your own immune cells engineered to target and kill cancer cells.
Shenyang, LiaoningAges 18–70 - NCT06306521Recruiting
Newborn screening for hundreds of genetic diseases by genome sequencing
This research study tests a new way to screen newborns for hundreds of genetic diseases using a sample of their blood or saliva. It aims to find conditions early so your baby can get the right care sooner.
San Diego, CaliforniaAges 1 day–4 weeks
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,427 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.